Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 70.60B | 71.20B | 71.67B | 69.79B | 59.44B | 55.81B |
Gross Profit | 14.49B | 14.76B | 15.04B | 14.43B | 14.73B | 14.00B |
EBITDA | 3.77B | 3.38B | 5.73B | 1.38B | 2.28B | 2.81B |
Net Income | 2.55B | -29.00M | 3.22B | -1.10B | 389.00M | 951.00M |
Balance Sheet | ||||||
Total Assets | 89.74B | 88.71B | 96.12B | 92.98B | 88.85B | 80.67B |
Cash, Cash Equivalents and Short-Term Investments | 7.44B | 8.74B | 13.42B | 6.95B | 6.60B | 9.32B |
Total Debt | 24.49B | 24.52B | 25.33B | 26.60B | 24.28B | 16.68B |
Total Liabilities | 48.09B | 46.92B | 53.31B | 53.46B | 47.05B | 38.46B |
Stockholders Equity | 43.96B | 44.25B | 44.52B | 40.61B | 42.18B | 42.30B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -4.21B | 8.15B | -1.92B | -10.12B | -8.93B |
Operating Cash Flow | 0.00 | -2.31B | 9.95B | 263.00M | 1.21B | 4.12B |
Investing Cash Flow | 0.00 | -2.15B | -1.77B | -662.00M | -9.56B | -10.59B |
Financing Cash Flow | 0.00 | -1.23B | -1.70B | 915.00M | 6.80B | 9.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥25.93B | 14.75 | 5.12% | 1.57% | 20.22% | ||
72 Outperform | ¥5.87B | 58.04 | 2.47% | 4.82% | -89.35% | ||
65 Neutral | ¥8.12B | 7.85 | 5.19% | 8.65% | 84.32% | ||
65 Neutral | ¥7.62B | 4.27 | 2.94% | 0.58% | ― | ||
56 Neutral | HK$24.88B | 3.87 | -2.03% | 6.54% | -0.32% | -67.68% | |
55 Neutral | ¥7.70B | 117.73 | 5.75% | 2.17% | -101.54% | ||
52 Neutral | ¥9.99B | 3.86 | 4.42% | -0.65% | -100.90% |